Pulse Biosciences, Inc. (PLSE)

$ 11.91
-0.04 (-0.33%)
Neutral
Symbol PLSE
Price $ 11.91
Beta 1.564
Volume Avg. 0.06M
Market Cap 0.353B
Shares () -
52 Week Range 11.605-45.82
1y Target Est -
DCF Unlevered PLSE DCF ->
DCF Levered PLSE LDCF ->
ROE -164.85% Strong Sell
ROA -92.32% Strong Sell
Operating Margin -
Debt / Equity 41.70% Neutral
P/E -
P/B 7.44 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PLSE news


Mr. Darrin R. Uecker
Healthcare
Medical Instruments & Supplies
Nasdaq Capital Market

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue primarily for dermatology applications by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.